Cargando…

To Investigate the Clinical Efficacy and Potential Mechanism of Tongxinluo Capsules in Preventing Coronary Restenosis Based on Meta-Analysis and Network Pharmacology Analysis

OBJECTIVE: The aim of this study is to evaluate the clinical efficacy of Tongxinluo capsules in preventing coronary restenosis based on meta-analysis and network pharmacology research methods and to preliminarily explore its intervention mechanism. METHODS: First, through meta-analysis, we comprehen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Wen-Xin, Jiang, Yi-Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897912/ https://www.ncbi.nlm.nih.gov/pubmed/36743461 http://dx.doi.org/10.1155/2023/7985459

Ejemplares similares

Experimental evidence and network pharmacology-based analysis reveal the molecular mechanism of Tongxinluo capsule administered in coronary heart diseases
por: Li, Guode, et al.
Publicado: (2020)

Tongxinluo Capsule Combined with Atorvastatin for Coronary Heart Disease: A Systematic Review and Meta-Analysis
por: Liu, Qiao, et al.
Publicado: (2021)

Efficacy and Safety of Different Courses of Tongxinluo Capsule as Adjuvant Therapy for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Hui, Jiaqi, et al.
Publicado: (2022)

Efficacy and Safety of Tongxinluo Capsule as Adjunctive Treatment for Unstable Angina Pectoris: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Li, Pengqi, et al.
Publicado: (2021)

Tongxinluo capsule in combination with conventional therapies for stable angina pectoris: A meta-analysis and systematic review
por: Feng, Ruli, et al.
Publicado: (2023)

Systematic Review of Tongxinluo Capsule on the Therapeutic Effect and Hemorheology of Patients with Transient Ischemic Attack
por: Yang, Peng, et al.
Publicado: (2021)

Potential Effectiveness of Chinese Patent Medicine Tongxinluo Capsule for Secondary Prevention After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Li, Min, et al.
Publicado: (2018)

Chinese Patent Medicine Tongxinluo Capsule for Hypertension: A Systematic Review of Randomised Controlled Trials
por: Wang, Jie, et al.
Publicado: (2014)

A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Study of the Effects of Tongxinluo Capsules in Acute Coronary Syndrome Patients with High On-Treatment Platelet Reactivity
por: Zhang, Lei, et al.
Publicado: (2018)

Coronary restenosis
Publicado: (1993)

Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysis
por: Meier, Pascal, et al.
Publicado: (2012)

Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI)
por: Chen, Shuxia, et al.
Publicado: (2017)

Clinical Efficacy Evaluation and Potential Mechanism of Zhishe Tongluo Capsule in the Treatment of Cerebral Infarction by Meta-Analysis Associated with Network Pharmacology
por: Geng, Zhi Xin, et al.
Publicado: (2022)

Effect of Pioglitazone in Preventing In-Stent Restenosis after Percutaneous Coronary Intervention in Patients with Type 2 Diabetes: A Meta-Analysis
por: Zhao, Shi-jie, et al.
Publicado: (2016)

Inhibiting leukocyte‐endothelial cell interactions by Chinese medicine Tongxinluo capsule alleviates no‐reflow after arterial recanalization in ischemic stroke
por: Liu, Shen, et al.
Publicado: (2023)

Coated stents to prevent restenosis in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2005)

Drug- and Gene-eluting Stents for Preventing Coronary Restenosis
por: Lekshmi, Kamali Manickavasagam, et al.
Publicado: (2017)

Effects of Probucol on Restenosis after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
por: Liu, Jichen, et al.
Publicado: (2015)

Tongxinluo promotes axonal plasticity and functional recovery after stroke
por: Wang, Xiaoting, et al.
Publicado: (2020)

Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study
por: Zhang, Mei, et al.
Publicado: (2019)

Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools
por: Xiong, Haijun, et al.
Publicado: (2020)

Efficacy of Jintiange Capsules in the Treatment of Osteoporosis: A Network Meta‐analysis
por: Sun, Jing, et al.
Publicado: (2019)

Intravascular imaging in coronary stent restenosis: Prevention, characterization, and management
por: Abouelnour, Amr, et al.
Publicado: (2022)

Tongxinluo Prevents Endothelial Dysfunction Induced by Homocysteine Thiolactone In Vivo via Suppression of Oxidative Stress
por: Zhang, Yi, et al.
Publicado: (2015)

Tongxinluo Improves Apolipoprotein E-Deficient Mouse Heart Function
por: Yuan, Guo-Qiang, et al.
Publicado: (2018)

Nanoparticle Drug- and Gene-eluting Stents for the Prevention and Treatment of Coronary Restenosis
por: Yin, Rui-Xing, et al.
Publicado: (2014)

Network pharmacology analysis and clinical verification of Jishe Qushi capsules in rheumatoid arthritis treatment
por: Li, Yujie, et al.
Publicado: (2023)

Predictive value of inflammatory factors on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Chu, Xin, et al.
Publicado: (2021)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Proteomics and network pharmacology of Ganshu Nuodan capsules in the prevention of alcoholic liver disease
por: Yang, Xiaonan, et al.
Publicado: (2023)

Association of smoking with restenosis and major adverse cardiac events after coronary stenting: A meta-analysis
por: Hu, Rui-ting, et al.
Publicado: (2015)

Outcomes of Percutaneous Coronary Intervention for In‐Stent Restenosis Versus De Novo Lesions: A Meta‐Analysis
por: Elbadawi, Ayman, et al.
Publicado: (2023)

Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients
por: Giacoppo, Daniele, et al.
Publicado: (2015)

Nanoparticulate carriers for the treatment of coronary restenosis
por: Brito, Luis, et al.
Publicado: (2007)

Network Pharmacology-Based Analysis on the Curative Effect of Kunxian Capsules against Rheumatoid Arthritis
por: Yan, Hong-Xia, et al.
Publicado: (2021)

Network Pharmacology-Based Approach to Investigate the Mechanisms of Mahai Capsules in the Treatment of Cardiovascular Diseases
por: Shi, Minjuan, et al.
Publicado: (2020)

Use of Network Pharmacology to Investigate the Mechanism of the Compound Xuanju Capsule in the Treatment of Rheumatoid Arthritis
por: Wei, Wenyang, et al.
Publicado: (2021)

Network Pharmacological Analysis and Experimental Study of the Antipharyngitis Mechanism of the Chaiqin Qingning Capsule
por: Wang, Can, et al.
Publicado: (2022)

Investigation of the efficacy and pharmacological mechanism of Danhong injections for treating chronic obstructive pulmonary disease: A PRISMA-compliant meta-analysis and network pharmacology analysis
por: Gao, Xiaoyu, et al.
Publicado: (2023)

Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease
por: Yi, Pengji, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t0b1b2tfu621b8ik182ookteij